188 related articles for article (PubMed ID: 22067884)
21. Is it time to re-appraise the role of compression in non-healing venous leg ulcers?
Guest JF; Charles H; Cutting KF
J Wound Care; 2013 Sep; 22(9):453-60. PubMed ID: 24005778
[TBL] [Abstract][Full Text] [Related]
22. Clinical and cost efficacy of advanced wound care matrices for venous ulcers.
Hankin CS; Knispel J; Lopes M; Bronstone A; Maus E
J Manag Care Pharm; 2012 Jun; 18(5):375-84. PubMed ID: 22663170
[TBL] [Abstract][Full Text] [Related]
23. Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the USA.
Guest JF; Ruiz FJ; Mihai A; Lehman A
Curr Med Res Opin; 2005 Jan; 21(1):81-92. PubMed ID: 15881478
[TBL] [Abstract][Full Text] [Related]
24. Potential cost-effectiveness of using a collagen-containing dressing in managing diabetic foot ulcers in the UK.
Guest JF; Singh H; Vowden P
J Wound Care; 2018 Mar; 27(3):136-144. PubMed ID: 29509110
[TBL] [Abstract][Full Text] [Related]
25. Cost-effective use of silver dressings for the treatment of hard-to-heal chronic venous leg ulcers.
Jemec GB; Kerihuel JC; Ousey K; Lauemøller SL; Leaper DJ
PLoS One; 2014; 9(6):e100582. PubMed ID: 24945381
[TBL] [Abstract][Full Text] [Related]
26. Economic analysis of VenUS I, a randomized trial of two bandages for treating venous leg ulcers.
Iglesias CP; Nelson EA; Cullum N; Torgerson DJ;
Br J Surg; 2004 Oct; 91(10):1300-6. PubMed ID: 15382101
[TBL] [Abstract][Full Text] [Related]
27. Aetiological treatment of venous leg ulcers with compression therapy: real-life outcomes with two different procedures.
Meaume S; Senet P; Thomé B; Aragno VA; Bohbot S; Fortin S; Boucley I; Michon-Pasturel U; Colboc H
J Wound Care; 2023 Oct; 32(10):615-623. PubMed ID: 37830834
[TBL] [Abstract][Full Text] [Related]
28. Comparative cost-effectiveness of four-layer bandaging in the treatment of venous leg ulceration.
Carr L; Philips Z; Posnett J
J Wound Care; 1999 May; 8(5):243-8. PubMed ID: 10531939
[TBL] [Abstract][Full Text] [Related]
29. The use of a collagen matrix in hard-to-heal venous leg ulcers.
Romanelli M; Mulder G; Paggi B; Macchia M; Panduri S; Dini V
J Wound Care; 2015 Nov; 24(11):543-4, 546-7. PubMed ID: 26551647
[TBL] [Abstract][Full Text] [Related]
30. [Management of venous leg ulcer by French physicians, diversity and related costs: a prospective medicoeconomic observational study].
Lévy E; Lévy P
J Mal Vasc; 2001 Feb; 26(1):39-44. PubMed ID: 11240528
[TBL] [Abstract][Full Text] [Related]
31. Cost of managing patients with venous leg ulcers.
Phillips CJ; Humphreys I; Thayer D; Elmessary M; Collins H; Roberts C; Naik G; Harding K
Int Wound J; 2020 Aug; 17(4):1074-1082. PubMed ID: 32383324
[TBL] [Abstract][Full Text] [Related]
32. Treatment of venous leg ulcers using bilayered living cellular construct.
Sawad AB; Turkistani F
J Comp Eff Res; 2020 Sep; 9(13):907-918. PubMed ID: 32969709
[No Abstract] [Full Text] [Related]
33. Economic evaluation of a randomized controlled trial of ultrasound therapy for hard-to-heal venous leg ulcers.
Chuang LH; Soares MO; Watson JM; Bland JM; Cullum N; Iglesias C; Kang'ombe AR; Torgerson D; Nelson EA;
Br J Surg; 2011 Aug; 98(8):1099-106. PubMed ID: 21509750
[TBL] [Abstract][Full Text] [Related]
34. Superabsorbent wound dressings versus foams dressings for the management of moderate-to-highly exuding venous leg ulcers in French settings: An early stage model-based economic evaluation.
Veličković VM; Prieto PA; Krga M; Jorge AM
J Tissue Viability; 2022 Aug; 31(3):523-530. PubMed ID: 35534319
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of compression stockings for the prevention of venous leg ulcer recurrence in Ontario.
Djalalov S; Sehatzadeh S; Keast DH; Wong WW
J Wound Care; 2020 Mar; 29(3):141-151. PubMed ID: 32160090
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of ChloraSolv in treating hard-to-heal venous leg ulcers.
Guest JF; Apelqvist J
J Wound Care; 2024 Jan; 33(1):4-13. PubMed ID: 38197275
[TBL] [Abstract][Full Text] [Related]
37. Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.
Davies CE; Woolfrey G; Hogg N; Dyer J; Cooper A; Waldron J; Bulbulia R; Whyman MR; Poskitt KR
Phlebology; 2015 Dec; 30(10):693-9. PubMed ID: 25300315
[TBL] [Abstract][Full Text] [Related]
38. Ulcer area reduction at 2 weeks predicts failure to heal by 24 weeks in the venous leg ulcers of patients living alone.
Parker CN; Finlayson KJ; Edwards HE
J Wound Care; 2016 Nov; 25(11):626-634. PubMed ID: 27827277
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
Guest JF; Smith H; Sladkevicius E; Jackson G
Clin Ther; 2009; 31 Pt 2():2398-415. PubMed ID: 20110049
[TBL] [Abstract][Full Text] [Related]
40. Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.
Guest JF; Atkin L; Aitkins C
Int Wound J; 2021 Dec; 18(6):889-901. PubMed ID: 33827144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
